Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLCAT: Colchicine in Non-Cardiac Surgery
NCT06279000Phase 3Recruiting
- Start
- Apr 2025
- Primary completion
- Mar 2028
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Myocardial injury, major adverse cardiovascular events (MACE). Started Apr 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
Myocardial injurymajor adverse cardiovascular events (MACE)
Beyond the preview
Go deeper on NCT06279000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06279000.